Abstract:In this study, we employed a recirculating photocatalytic fixed-bed reactor featuring a TiO2/β-Bi2O3 (TB) composite as a photocatalyst immobilized onto borosilicate glass beads for the degradation of the water-dissolved pharmaceutical compound diclofenac amide (DCFA) under UV-LED illumination. Our findings from the DCFA degradation runs revealed that the initial concentration (Co) and the volumetric recirculation flow rate (Q) exert minimal influence on the DCFA degradation rate, indicating the absence of mass transfer limitations at the chosen Q. A kinetic model, developed in alignment with the experimental data, facilitated the calculation of kinetic adsorption (k1 = 0.15 (ppm h)-1, Keq = 15 ppm−1, St = 4.3 ppm) and reaction rate constants (kr = 0.015 h−1). These constants were pivotal in determining the photocatalytic space yield (PSTY—0.45 × (10-6 m3 water m−3 reactor day−1 kW−1 lamp)) for the employed reactor system. The results from three consecutive cycles of DCFA degradation, conducted with the same TB-coated glass beads, demonstrated that the adsorption of DCFA in the dark primarily occurs through the glass material of the beads. Upon exposure to light, the DCFA degradation rate remained constant across all three oxidation cycles. Analysis of the kobs values for cycle 1 (0.0041 ± 0.00067 h−1, R2 = 0.91), cycle 2 (0.0083 ± 0.0013 h−1, R2 = 0.93), and cycle 3 (0.0073 ± 0.001 h−1, R2 = 0.94) indicated an initial excessive leaching of weakly bound TB powder during the first DCFA degradation cycle, potentially resulting in light scattering and reduced photon absorption. Nevertheless, the coatings exhibited reusability over three DCFA degradation cycles, highlighting their stability and reproducible activity. Furthermore, the long-term stability of the coated TB beads was demonstrated by comparing the photocatalytic activity between the present day and two years ago. Remarkably, comparable activity levels were achieved both today (kobs = 0.0085 ± 0.0035 h−1, R2 = 0.71) and two years ago (kobs = 0.0071 ± 0.0014 h−1, R2 = 0.90). These obtained results offer valuable insights for the refinement and optimization of fixed-bed photoreactors in the context of wastewater treatment.

TiO2-assisted photocatalytic degradation of diclofenac, metoprolol, estrone and chloramphenicol as endocrine disruptors in water

Photocatalytic Degradation of 17 beta-estradiol, 17 alpha-ethinylestradiol and Bisphenol A in Different Water Matrices

Photocatalytic decomposition of selected biologically active compounds in environmental waters using TiO2/polyaniline nanocomposites: Kinetics, toxicity and intermediates assessment

DEGRADATION OF 17 alpha-ETHINYLESTRADIOL AND ITS ESTROGENIC ACTIVITY REMOVAL BY TiO2 NANOTUBE ARRAYS IN PHOTOCATALYSIS

Comparison of different Advanced Oxidation Processes (AOPs) and Photocatalysts for the degradation of Diclofenac

Removal of Pharmaceuticals from Aqueous Solutions by Photodegradation Using TiO2 and Sn/Zn/Fe-Doped TiO2 as Photocatalyst Under Ultraviolet and Visible Light

Synthesis of Selected Mixed Oxide Materials with Tailored Photocatalytic Activity in the Degradation of Tetracycline

Adsorption and Photocatalytic Degradation Kinetics of Pharmaceuticals by TiO2 Nanowires During Water Treatment

Titanium Dioxide-Based Photocatalysts for Degradation of Emerging Contaminants including Pharmaceutical Pollutants

Photocatalytic degradation of diclofenac sodium salt: adsorption and reaction kinetic studies

Palladium-modified TiO2 films in a photocatalytic microreactor: evaluation of radiation absorption properties and pollutant degradation efficiency

Treatability of diclofenac and triclosan solutions by catalytic and photocatalytic oxidation processes

Degradation of pesticides chlorpyrifos, cypermethrin and chlorothalonil in aqueous solution by TiO2 photocatalysis

Photocatalytic degradation of diclofenac amide in a fixed-bed reactor using TiO2/β-Bi2O3: Process optimization and stability analysis

Photocatalytic degradation of atenolol in aqueous titanium dioxide suspensions: Kinetics, intermediates and degradation pathways

Photocatalytic Degradation of Pharmaceutical Residues from Water and Sewage Effluent Using Different TiO2 Nanomaterials

Titanium dioxide mediated photocatalytic degradation of 17beta-estradiol in aqueous solution.

Degradation of Contaminants of PPCPs by Photocatalysis for Water Purification: Kinetics, Mechanisms, and Cytotoxicity Analysis

Simultaneous removal of E1, E2, EE2 and levonorgestrel from water using TiO2 catalyst anchored on activated carbon: Processes optimization, materials characterization, and assessment of the estrogenicity reduction

Study of application of titania catalysts on solar photocatalysis: Influence of type of pollutants and water matrices

Removal of Endocrine-Disrupting Compounds, Estrogenic Activity, and Escherichia Coliform from Secondary Effluents in a TiO2-Coated Photocatalytic Reactor